학술논문
Tixagevimab and Cilgavimab (Evusheld – AstraZeneca) efficacy in preventing COVID infection in immunocompromised patients
Document Type
Abstract
Author
Source
In The Journal of Allergy and Clinical Immunology February 2023 151(2) Supplement:AB196-AB196
Subject
Language
ISSN
0091-6749